BioAge Labs (BIOA) Revenue (2025 - 2026)
BioAge Labs (BIOA) posted Revenue of $2.8 million for Q1 2026, down 9.94% sequentially from $3.1 million in Q4 2025, and up 91.04% YoY from $1.5 million in Q1 2025.
BioAge Labs (BIOA) Revenue (2025 - 2026) Analysis & Trends
BioAge Labs has reported Revenue for 2 years, with the latest figure at $2.8 million in Q1 2026.
- Quarterly Revenue rose 91.04% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (up 610.96% YoY) and the FY2025 annual result came in at $9.0 million, changed N/A from the prior year.
- Revenue declined to $2.8 million in Q1 2026 per BIOA's latest filing, from $3.1 million in the prior quarter.
- Over five years, Revenue peaked at $3.1 million in Q4 2025 and troughed at $1.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 453.32 Mn | 453.32 Mn | -14.23 Mn | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.45 Mn |
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 1.45 Mn |